|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings | ||||||||||||||||||||
| Fixtures and tenant improvements | ||||||||||||||||||||
| Total real estate rental property | ||||||||||||||||||||
| Less: Accumulated depreciation | ||||||||||||||||||||
| Real estate rental property, net | ||||||||||||||||||||
| Construction in progress and land | ||||||||||||||||||||
| Total real estate assets, net | ||||||||||||||||||||
| Investments in and advances to joint ventures | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Amounts receivable from Curbline | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Assets related to discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Senior notes, net | ||||||||||||||||||||
| Term loan, net | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Total unsecured indebtedness | ||||||||||||||||||||
| Mortgage indebtedness, net | ||||||||||||||||||||
| Indebtedness | ||||||||||||||||||||
| Amounts payable to Curbline | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Liabilities related to discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SITE Centers Equity | ||||||||||||||||||||
| Cumulative redeemable preferred shares | ||||||||||||||||||||
| Class A Cumulative Redeemable Preferred Shares | ||||||||||||||||||||
| Common shares, with par value, $0.10 stated value; 75,000,000 shares authorized; 52,480,384 and 52,467,187 shares issued at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated distributions in excess of net income | ||||||||||||||||||||
| Deferred compensation obligation | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Less: Common shares in treasury at cost: 5,510 and 4,847 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
